Health Trials

Undifferentiated Leukemia

2

Review clinical trials related to Undifferentiated Leukemia. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

A Phase I Study of Hyper-CVAD In Combination With Venetoclax In Pediatric Patients With Relapsed or Refractory Acute Leukemias That Are of the Lymphoid Lineage Including Bi-Phenotypic or Undifferentiated Leukemias

To find the recommended dose of hyper-CVAD in combination with venetoclax that can be given to participants with relapsed or refractory leukemia.

Participants needed: 22
Trial details
Phase: Phase 1Age: 2-21Biological sex: AllType: InterventionalSponsor: M.D. Anderson Cancer CenterUpdated: Jun 24, 2026Locations: 1
Eligibility criteria

Pediatric, adolescent, or young adult patients with relapsed or refractory acute... [+21]

curatively treated non-melanomatous skin cancer, [+12]

Read more
Status: Recruiting

Allo HSCT Using RIC and PTCy for Hematological Diseases

This is a Phase II study following subjects proceeding with our Institutional non-myeloablative cyclophosphamide/ fludarabine/total body irradiation (TBI) preparative regimen followed by a related, unrelated, or partially matched family donor stem cell infusion using post-transplant cyclophosphamide (PTCy), sirolimus and MMF GVHD prophylaxis.

Participants needed: 56
Trial details
Phase: Phase 2Age: Up to 75Biological sex: AllType: InterventionalSponsor: Masonic Cancer Center, University of MinnesotaUpdated: Jul 1, 2025Locations: 1
Eligibility criteria

Age 0 to 75 years of age with Karnofsky score ≥ 70% (≥ 16 years) or Lansky score... [+12]

Pregnant or breast feeding. The agents used in this study include Pregnancy Cate... [+6]

Read more